Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

2423studies indexed1086with human data145registered trials2091carry a numeric findingLibrarian added 0 studies today
Showing 38 studiesSortNewest indexed ▾
B
grade
Impaired fasting glucose is comparable to diabetes mellitus in predicting mortality and cardiovascular events in patients undergoing peritoneal dialysis: the role of β-cell function and insulin resistance.
Erythropoietin (EPO) · Renal failure · 2026 · Observational · n=216
Impaired fasting glucose in patients on peritoneal dialysis is associated with mortality and cardiovascular risks similar to those seen in diabetes mellitus.
IFG independently predicted all-cause mortality (HR, 2.48; 95% CI, 1.16-5.32; p=0.02).
B
grade
The relationship between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and tubular atrophy/interstitial fibrosis in patients with IgA nephropathy.
Erythropoietin (EPO) · Renal failure · 2026 · Observational · n=400
Elevated NHHR is associated with an increased risk of tubular atrophy/interstitial fibrosis in patients with IgA nephropathy, but the clinical implications of this finding need further investigation.
NHHR was positively correlated with T lesions (r = 0.229, p < 0.001).
B
grade
Association Between Perioperative Daprodustat Use and Early Posttransplant Graft Function in Living Donor Kidney Transplantation: A Propensity Score-Matched Retrospective Study.
Erythropoietin (EPO) · Current therapeutic research, clinical and experimental · 2026 · Observational · n=64
Daprodustat may improve early graft function in living donor kidney transplantation, but further studies are needed to confirm these findings.
Week 1 estimated glomerular filtration rate: 53.3 ± 16.1 vs control 41.9 ± 17.9 mL/min/1.73 m²; P = 0.001
B
grade
Plasma proteome screen of individuals with elevated blood counts to identify diagnostic signatures and biomarkers inherent to patients with myeloproliferative neoplasms
Erythropoietin (EPO) · biorxiv-preprint · 2026 · Observational
The study identifies TFRC as a promising biomarker for diagnosing polycythemia vera, especially when combined with serum erythropoietin.
Diagnostic accuracy for identifying PV increased to 99.3% when combined with serum erythropoietin.
A
grade
Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial.
Erythropoietin (EPO) · Nephrology (Carlton, Vic.) · 2025 · RCT
Efepoetin alfa showed a 6.3% higher response rate compared to methoxy polyethylene glycol-epoetin beta in correcting anemia in CKD patients, but the clinical significance of this difference is uncertain.
Difference in response rates was 6.3% with 95% CI -3.1% to 15.5%.
A
grade
Impact of intravenous iron or exogenous erythropoietin on hemoglobin mass, exercise performance, and acute mountain sickness during altitude acclimatization.
Erythropoietin (EPO) · Journal of applied physiology (Bethesda, Md. : 1985) · 2025 · RCT
Neither intravenous iron nor EPO treatment improved hemoglobin mass, exercise performance, or symptoms of acute mountain sickness during high-altitude exposure.
Absolute Hbmass (g) increased from SL and day 1 to day 13 (P < 0.0001).
B
grade
The impact of multiple long-term conditions on mortality, progression to kidney failure and health-related quality of life among people with chronic kidney disease: a multicentre cohort study (NURTuRE-CKD).
Erythropoietin (EPO) · Annals of medicine · 2026 · Observational · n=2996
Higher numbers of comorbidities in chronic kidney disease patients are linked to increased mortality and worse quality of life, but not to CKD progression.
Adjusted hazard ratios for mortality increased with comorbidity count: 1.37 (2), 1.45 (3), 1.54 (4), and 1.80 (≥5), with significance at ≥4 comorbidities.
Showing 25 of 38